Merck & Co Inc
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
Did you know?
A mega-cap stock valued at $284B.
Current Price
$114.62
+1.53%GoodMoat Value
$189.57
65.4% undervaluedProfile
Valuation (TTM)
Market Cap$284.49B
P/E15.59
EV$321.89B
P/B5.41
Shares Out2.48B
P/Sales4.38
Revenue$65.01B
EV/EBITDA11.30
Merck & Co Inc (MRK) Stock News
MRK Stock News & Headlines
Latest stock news and headlines for Merck & Co Inc (MRK). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $114.62. Market cap: $284.49B. Sector: Healthcare. Industry: Drug Manufacturers - General. This page aggregates the latest news articles relevant to MRK from financial news sources, helping investors stay current on events that may impact Merck & Co Inc's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Merck & Co Inc (MRK).